Immunogenicity 9847

summary
Sample ID
3812
Response
Negative
Tumor Type
Bile duct cancer
Gene Symbol
OR2A7
Transcript ID
ENST00000493325
HLA INFO
DQA*01:03 / DQB*02:02
TCR INFO

No TCR info found!

T cell Tumor cell { DQA*01:03 DQB*02:02
sequence
Full length protein sequence (310 aa)
MGDNI
1
TSITE
6
FLLLG
11
FPVGP
16
RIQML
21
LFGLF
26
SLFYV
31
FTLLG
36
NGTIL
41
GLISL
46
DSRLH
51
APMYF
56
FLSHL
61
AVVDI
66
AYACN
71
TVPRM
76
LVNLL
81
HPAKP
86
ISFAG
91
RMMQT
96
FLFST
101
FAVTE
106
CLLLV
111
VMSYD
116
LYVAI
121
CHPLR
126
YLAIM
131
TWRVC
136
ITLAV
141
TSWTT
146
GVLLS
151
LIHLV
156
LLLPL
161
PFCRP
166
QKIYH
171
FFCEI
176
LAVLK
181
LACAD
186
THINE
191
NMVLA
196
GAISG
201
LVGPL
206
STIVV
211
SYMCI
216
LCAIL
221
QIQSR
226
EVQRK
231
AFCTC
236
FSHLC
241
VIGLF
246
YGTAI
251
IMYVG
256
PRYGN
261
PKEQK
266
KYLLL
271
FHSLF
276
NPMLN
281
PLICS
286
LRNSE
291
VKNTL
296
KRVLG
301
VERAL
306
Mutation Information
DNA mutation:
None
Peptide Range:
258 ~ 282
Mut AA position:
270 (13 in Wild Type peptide)
Alignment
Wild Type:
"YVGPRYGNPKEQKKYLLLFHSLFNP
||||||||||||.||||||||||||
Mutant:
YVGPRYGNPKEQRKYLLLFHSLFNP"
reference

Science, 2015

Immunogenicity of somatic mutations in human gastrointestinal cancers

Gene Name (from Reference) OR2A7

clinic trial
Checkpoint Blockade

None

ACT

None

Vaccination

None

Curative Effect

None

experiment
minimal_peptide

None

Antigen Type

TMG RNA

T-cell Source

TILs

APC Type

None

Assay

IFNg ELISPOT assay